{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:34:39Z","timestamp":1779201279339,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ijcard.2013.10.079","type":"journal-article","created":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T03:29:37Z","timestamp":1382930977000},"page":"246-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina \u2014 Final 3-year follow-up"],"prefix":"10.1016","volume":"170","author":[{"given":"Anders Bruun","family":"Mathiasen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandana","family":"Haack-S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Kastrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2013.10.079_bb0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s13167-011-0062-5","article-title":"Stem cells therapy for cardiovascular repair in ischemic heart disease: how to predict and secure optimal outcome?","volume":"2","author":"Kastrup","year":"2011","journal-title":"EPMA J"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/hc0102.101442","article-title":"Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart","volume":"105","author":"Toma","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/CIRCHEARTFAILURE.108.843243","article-title":"Clinical outcome 2years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction","volume":"3","author":"Assmus","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0020","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/hrt.2009.178913","article-title":"Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study","volume":"95","author":"Beitnes","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0025","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.amjcard.2005.09.132","article-title":"Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease","volume":"97","author":"Fuchs","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0030","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00392-011-0327-y","article-title":"Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy","volume":"100","author":"Leistner","year":"2011","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0035","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1161\/CIRCULATIONAHA.106.687376","article-title":"Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I\/IIa double-blind, randomized controlled trial","volume":"115","author":"Losordo","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0040","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/CIRCRESAHA.111.245993","article-title":"Intramyocardial, autologous CD34+ cell therapy for refractory angina","volume":"109","author":"Losordo","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0045","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1093\/eurheartj\/ehp374","article-title":"Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial","volume":"30","author":"Meyer","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0050","doi-asserted-by":"crossref","first-page":"II213","DOI":"10.1161\/01.CIR.0000138398.77550.62","article-title":"Improved exercise capacity and ischemia 6 and 12months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy","volume":"110","author":"Perin","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0055","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ahj.2011.01.028","article-title":"A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF)","volume":"161","author":"Perin","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0060","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.jacc.2009.02.051","article-title":"The BALANCE study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction","volume":"53","author":"Yousef","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0065","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/eurjhf\/hfq095","article-title":"The acute and long-term effects of intracoronary stem cell transplantation in 191 patients with chronic heARt failure: the STAR-heart study","volume":"12","author":"Strauer","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0070","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1093\/eurheartj\/ehm485","article-title":"Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial)","volume":"28","author":"Tse","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0075","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1001\/jama.2009.685","article-title":"Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial","volume":"301","author":"van","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jcin.2008.11.003","article-title":"One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study)","volume":"2","author":"Dib","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0085","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4244\/EIJV6I7A139","article-title":"Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial","volume":"6","author":"Duckers","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0090","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.107.734103","article-title":"The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation","volume":"117","author":"Menasche","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0095","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ahj.2011.07.020","article-title":"A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction","volume":"162","author":"Povsic","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0100","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2217\/fca.09.42","article-title":"Mesenchymal stromal cells for cardiovascular repair: current status and future challenges","volume":"5","author":"Mathiasen","year":"2009","journal-title":"Future Cardiol"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0105","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1242\/jcs.02932","article-title":"Mesenchymal stem cells reside in virtually all post-natal organs and tissues","volume":"119","author":"da Silva","year":"2006","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0110","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/00365510701601681","article-title":"Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy","volume":"68","author":"Haack-Sorensen","year":"2008","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0115","first-page":"552","article-title":"Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery","volume":"18","author":"Chen","year":"2006","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.amjcard.2004.03.034","article-title":"Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction","volume":"94","author":"Chen","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/14017431.2011.569571","article-title":"Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina","volume":"45","author":"Friis","year":"2011","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0130","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3727\/096368912X636830","article-title":"Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina - one year follow-up","volume":"22","author":"Haack-Sorensen","year":"2013","journal-title":"Cell Transplant"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0135","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","article-title":"A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction","volume":"54","author":"Hare","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0140","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jacc.2011.09.065","article-title":"First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction","volume":"59","author":"Houtgraaf","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0145","first-page":"321","article-title":"Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium","volume":"65","author":"Katritsis","year":"2005","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/europace\/eul184","article-title":"Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells","volume":"9","author":"Katritsis","year":"2007","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0155","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/14653240701322235","article-title":"The influence of freezing and storage on the characteristics and functions of human mesenchymal stromal cells isolated for clinical use","volume":"9","author":"Haack-Sorensen","year":"2007","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0160","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2004.12.068","article-title":"Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One Trial","volume":"45","author":"Kastrup","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0165","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/eurheartj\/ehn233","article-title":"Release of biomarkers of myocardial damage after direct intramyocardial injection of genes and stem cells via the percutaneous transluminal route","volume":"29","author":"Baldazzi","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0170","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/eurheartj\/ehl117","article-title":"Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease","volume":"27","author":"Ripa","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0175","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0180","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ahj.2012.05.026","article-title":"Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial)","volume":"164","author":"Mathiasen","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0185","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2217\/rme.12.17","article-title":"Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design","volume":"7","author":"Qayyum","year":"2012","journal-title":"Regen Med"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0190","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3727\/096368910X509068","article-title":"Beneficial effects of VEGF secreted from stromal cells in supporting endothelial cell functions: therapeutic implications for critical limb ischemia","volume":"19","author":"Cobellis","year":"2010","journal-title":"Cell Transplant"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0195","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3727\/096368910X494911","article-title":"Factors affecting residence time of mesenchymal stromal cells (MSC) injected into the myocardium","volume":"19","author":"Westrich","year":"2010","journal-title":"Cell Transplant"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0200","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3727\/096368910X508762","article-title":"Mesenchymal stem cells: mechanisms of immunomodulation and homing","volume":"19","author":"Yagi","year":"2010","journal-title":"Cell Transplant"},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2013.10.079_bb0205","first-page":"190","article-title":"Mobilization of stem cells in cardiovascular disease. Improvement of vascularization, cardiac function and arrhythmias","volume":"101","author":"Nikol","year":"2006","journal-title":"Med Klin (Munich)"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0210","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.scr.2011.01.001","article-title":"Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction","volume":"6","author":"Timmers","year":"2011","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0215","doi-asserted-by":"crossref","first-page":"14068","DOI":"10.1073\/pnas.0706760104","article-title":"Human cardiac stem cells","volume":"104","author":"Bearzi","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0220","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF03086247","article-title":"Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells","volume":"17","author":"Chamuleau","year":"2009","journal-title":"Neth Heart J"},{"key":"10.1016\/j.ijcard.2013.10.079_bb0225","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/eurheartj\/ehi818","article-title":"A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction","volume":"27","author":"Freyman","year":"2006","journal-title":"Eur Heart J"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313019232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313019232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:34:31Z","timestamp":1759091671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527313019232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0167527313019232"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.10.079","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina \u2014 Final 3-year follow-up","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.10.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}